People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...

About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be ...

It’s similar with multiple sclerosis. Actually, there are so many good drugs out there. A lot of the market has already been ...

The companies will deliver products for diabetes and weight control in specific nations across the Middle East.

E arlier this month, Kourtney Kardashian’s supplement brand, Lemme, joined the growing market for Ozempic dupes with the ...

Ozempic continues to surge in popularity for managing type 2 diabetes and off-label weight loss, but are there natural ...

Results of the human clinical trial will be shared with LifeVantage Consultants at Market Connect in Kansas City, October ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

The company's shares have plummeted about 90 percent this year due to the rising popularity of GLP-1 drugs like Ozempic and ...

GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught ...

In 1970, with a degree from the medical school of the University of Copenhagen (UCPH), Professor Jens Juul Holst embarked on ...

Discover the potential of GLP-1 medications like Ozempic and Mounjaro in treating a wide range of conditions, from diabetes to addiction.